Fair value · Adagene Inc. (ADAG) · updated 2026-10-04 · from 20-F FY2025
Adagene trades at $2.85. We are not reading assumptions out of that price: this is a depositary receipt and we cannot show whether its per-share figures are stated per ADS or per ordinary share, so these methods are withheld rather than shown at a scale we cannot verify.
Everything below is unaffected: the filed statements, the filing they came from, and ADAG’s growth history are all as reported.
The filing behind these numbers
Adagene Inc.- Revenue
- $7.7M
- Diluted EPS
- $-0.30
- Free cash flow
- $-15.7M
- operating cash flow − capital expenditure
- Diluted shares
- 59.0M
- weighted average
20-F FY2025 · fiscal year ended 2025-12-31 · filed 2026-04-01 · accession 0001104659-26-038612
Open this filing on sec.govNeed ADAG data in your own agent or pipeline?
The valuation data behind this page — DCF fair value, margin of safety, PE vs industry, analyst estimates — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.